首页> 外文OA文献 >High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcome

【2h】

High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcome

机译：急性髓细胞性白血病患者母细胞中的INDO（吲哚胺2,3-二加氧酶）mRNA水平高，预示临床结局较差

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Chamuleau M.E.D. (Martine); Loosdrecht A.A. (Arjan) van de; Hess C.J. (Corine); Janssen J.J.W.M. (Jeroen); Zevenbergen A. (Adri); Delwel H.R. (Ruud); Valk P.J.M. (Peter); Löwenberg B. (Bob); Ossenkoppele G.J. (Gert);
展开▼
作者单位

展开▼
年度 2008
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcome | Haematologica [J] . Martine E.D. Chamuleau, Arjan A. van de Loosdrecht, Corine J. Hess, Haematologica . 2008,第12期

机译：急性髓细胞性白血病患者原始细胞中的高INDO（吲哚胺2,3-二加氧酶）mRNA水平预示临床结局不佳血液学
2. Quantitative Assessment of Indoleamine 2,3-Dioxygenase (IDO) Expression at Diagnosis Predicts Clinical Outcome in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation [J] . Parisi Sarah, Ragaini Simone, Ocadlikova Darina, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：indoleamine 2,3-二恶英酶（IDO）表达在诊断中的定量评估预测急性髓细胞白血病患者患者进行同种异体干细胞移植的临床结果
3. Expression of indoleamine 2,3-dioxygenase in leukemic cells indicates an unfavorable prognosis in acute myeloid leukemia patients with intermediate-risk cytogenetics [J] . Fukuno Kenji, Hara Takeshi, Tsurumi Hisashi, Leukemia and lymphoma . 2015,第5期

机译：吲哚胺2,3-双加氧酶在白血病细胞中的表达表明具有中等风险细胞遗传学的急性髓性白血病患者预后不良
4. Clinical aspects of indoleamine 2,3-dioxygenase(IDO)-initiated tryptophan metabolism: IDO is atarget of drug discovery for various diseases [C] . O. Takikaw International Study Group for Tryptophan Research . 2007

机译：吲哚胺2,3-二恶英酶（IDO） - intinited色氨酸代谢的临床方面：IDO是各种疾病的药物发现的悖论
5. Malglycemia and health outcomes in hospitalized patients with Acute Myeloid Leukemia [D] . Storey, Susan 2015

机译：住院的急性髓性白血病患者的血糖和健康状况
6. Indoleamine 23-dioxygenase 1 (IDO1) activity in leukemia blasts correlates with poor outcome in childhood acute myeloid leukemia [O] . Valentina Folgiero, Bianca M. Goffredo, Perla Filippini, 2014

机译：白血病母细胞中吲哚胺23-双加氧酶1（IDO1）的活性与儿童急性髓细胞性白血病的不良预后相关
7. High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcome [O] . Chamuleau, Martine, Loosdrecht, Arjan, Hess, Corine, 2008

机译：急性髓细胞性白血病患者母细胞中的INDO（吲哚胺2,3-二加氧酶）mRNA水平高，预示临床结局较差
8. Indoleamine 2,3 Dioxygenase (IDO) as a Mediator of Myeloid Derived Suppressor Cell Function in Breast Cancer [R] . Yang, L. 2009

机译：吲哚胺2,3双加氧酶（IDO）作为乳腺癌骨髓来源抑制细胞功能的介质

High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcome

著录项

引文网络

相似文献

相关主题

期刊订阅